Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Post diagnosis aspirin improves survival in all gastrointestinal cancers

ECC 2015

Published: 28 Sep 2015

Views: 2086

Rating:

Save

Ms Martine Frouws - Leiden University Medical Center, Leiden, Netherlands

Ms Martine Frouws presents, at a press conference at ECC 2015, the findings of a large study that has shown that aspirin improves survival in patients with tumours situated throughout the gastrointestinal tract

Read the news story or watch the interview for more.

Related Videos

Nivolumab plus ipilimumab improves on chemo in previously untreated MSI-H/dMMR...

Dr Thierry André - Sorbonne Université, Paris, France

Nivolumab plus ipilimumab improves on chemo in previously untreated MSI-H/dMMR mCRC ( Dr Thierry André - Sorbonne Université, Paris, France )

ESMO 2023: Highlights and analysis

Dr Bishal Gyawali - Queen's University, Kingston, Canada

ESMO 2023: Highlights and analysis ( Dr Bishal Gyawali - Queen's University, Kingston, Canada )

Active surveillance for oesophageal cancer shows improved HRQoL compared to...

Dr Berend Van der Wilk - Erasmus MC Cancer Institute, Rotterdam, The Netherlands

Active surveillance for oesophageal cancer shows improved HRQoL compared to standard surgery ( Dr Berend Van der Wilk - Erasmus MC Cancer Institute, Rotterdam, The Netherlands )

OncoAlert Round Up for August 4th - 10th, 2023

Dr Gil Morgan - Executive Director, OncoAlert

OncoAlert Round Up for August 4th - 10th, 2023 ( Dr Gil Morgan - Executive Director, OncoAlert )

OncoAlert round up July 28th to August 3rd, 2023

Dr Gil Morgan - Executive Director, OncoAlert

OncoAlert round up July 28th to August 3rd, 2023 ( Dr Gil Morgan - Executive Director, OncoAlert )

Potential benefit to response rates from trastuzumab added to perioperative...

Dr Anna Wagner - The University of Lausanne, Lausanne, Switzerland, Co-chair of...

Potential benefit to response rates from trastuzumab added to perioperative chemotherapy for patients with HER-2+ GC ( Dr Anna Wagner - The University of Lausanne, Lausanne, Switzerland, Co-chair of the EORTC Gastric Cancer Task Force )

The parotid gland; an unusual site of colorectal cancer metastasis

Dr Paula Isabel Franco - St Luke’s Medical Center, Malina, Philippines

The parotid gland; an unusual site of colorectal cancer metastasis ( Dr Paula Isabel Franco - St Luke’s Medical Center, Malina, Philippines )

Pembro plus gemcitabine and cisplatin potential option for metastatic or...

Dr Katie Kelley - University of California San Francisco, San Francisco, USA

Pembro plus gemcitabine and cisplatin potential option for metastatic or unresectable biliary tract cancer ( Dr Katie Kelley - University of California San Francisco, San Francisco, USA )

Cetuximab with XELOX or XELIRI is tolerable and effective in RAS wild-type mCRC

Dr Jamal Zekri - King Faisal Specialist Hospital & Research Centre, Riyadh...

Cetuximab with XELOX or XELIRI is tolerable and effective in RAS wild-type mCRC ( Dr Jamal Zekri - King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia )

More from ecancer